SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-97-000573
Filing Date
1997-02-13
Accepted
1997-02-13 00:00:00
Documents
1
Group Members
E.M. WARBURG, PINCUS & CO., LLCWARBURG PINCUS CAPITAL CO LPWARBURG, PINCUS & CO.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES INC SC 13G 18706
  Complete submission text file 0000950135-97-000573.txt   20800
Mailing Address
Business Address 195 ALBANY STREET CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 97530084
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS & CO 466 LEXINGTON AVENUE 10TH FLOOR NEW YORK NY 10017-3147
Business Address 466 LEXINGTON AVENUE 10TH FLOOR C/O E M WARBURG PINCUS & CO NEW YORK NY 10017-3147 2128780600
WARBURG PINCUS CAPITAL CO LP (Filed by) CIK: 0000898600 (see all company filings)

IRS No.: 061183391 | State of Incorp.: DE | Fiscal Year End: 1231